63 results
S-8
EX-4.6
VKTX
Viking Therapeutics Inc
22 May 24
Registration of securities for employees
4:33pm
or in the Offering will in any way alter the at will nature of a Participant’s employment or amend a Participant’s employment contract, if applicable … : (a) nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction of any nature; (b) federal, state, local
S-8
EX-4.2
VKTX
Viking Therapeutics Inc
22 May 24
Registration of securities for employees
4:33pm
executed thereunder or in connection with any Award will constitute any promise or commitment by the Company or an Affiliate regarding the fact or nature … )“Governmental Body” means any: (a) nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction of any nature; (b) U.S
8-K
EX-99.1
VKTX
Viking Therapeutics Inc
27 Feb 24
Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity
7:04am
in severity. The majority of TEAEs that were gastrointestinal (GI) in nature (95%) were also reported as mild or moderate. Nausea was reported among
S-3ASR
EX-5.1
kyw2cv2ofdnpbkbn7et
26 Jul 23
Automatic shelf registration
5:26pm
S-3ASR
EX-4.2
7k38tdgnh 1b9
26 Jul 23
Automatic shelf registration
5:26pm
8-K
EX-1.1
hfq1t
31 Mar 23
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
5:27pm
424B5
buyecaebklnu go
31 Mar 23
Prospectus supplement for primary offering
5:24pm
424B5
x8y95rzay4055 gyru
29 Mar 23
Prospectus supplement for primary offering
4:01pm